GEP19981392B - N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof - Google Patents
N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereofInfo
- Publication number
- GEP19981392B GEP19981392B GEAP19931112A GEAP1993001112A GEP19981392B GE P19981392 B GEP19981392 B GE P19981392B GE AP19931112 A GEAP19931112 A GE AP19931112A GE AP1993001112 A GEAP1993001112 A GE AP1993001112A GE P19981392 B GEP19981392 B GE P19981392B
- Authority
- GE
- Georgia
- Prior art keywords
- preparing
- drug
- indole derivatives
- oxazolidin
- indol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1. Technical result Creation of novel, more active and less toxic agents of this class. 2. Essence N,N-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1H-indol-3-yl)ethylamine is deleted. Indole derivatives of formula I are useful in prophylaxis of clinical states for which administration of "5-HT1- like receptor agonist is recommended. Also described are method of preparation thereof, drug based on indole derivatives of formula I and method of preparing drug; EFFECT: improved properties of the drug and more efficient preparation method thereof 3. Field of Application Medicine, pharmacology.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909012672A GB9012672D0 (en) | 1990-06-07 | 1990-06-07 | Therapeutic heterocyclic compounds |
PCT/GB1991/000908 WO1991018897A1 (en) | 1990-06-07 | 1991-06-06 | Therapeutic heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP19981392B true GEP19981392B (en) | 1998-11-10 |
Family
ID=10677193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP19931112A GEP19981392B (en) | 1990-06-07 | 1993-07-22 | N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof |
Country Status (7)
Country | Link |
---|---|
GB (1) | GB9012672D0 (en) |
GE (1) | GEP19981392B (en) |
RU (1) | RU2110517C1 (en) |
SA (1) | SA91120058B1 (en) |
SG (1) | SG52664A1 (en) |
TW (1) | TW223072B (en) |
ZA (1) | ZA914340B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8600398D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-06-07 GB GB909012672A patent/GB9012672D0/en active Pending
-
1991
- 1991-06-05 TW TW80104430A patent/TW223072B/zh not_active IP Right Cessation
- 1991-06-06 SG SG1996007538A patent/SG52664A1/en unknown
- 1991-06-06 RU SU5011473/04A patent/RU2110517C1/en active
- 1991-06-06 ZA ZA914340A patent/ZA914340B/en unknown
- 1991-08-05 SA SA91120058A patent/SA91120058B1/en unknown
-
1993
- 1993-07-22 GE GEAP19931112A patent/GEP19981392B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB9012672D0 (en) | 1990-08-01 |
ZA914340B (en) | 1993-02-24 |
RU2110517C1 (en) | 1998-05-10 |
TW223072B (en) | 1994-05-01 |
SA91120058B1 (en) | 2005-11-30 |
SG52664A1 (en) | 1998-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG60102B2 (en) | Method for preparing of 5-fluoro-2[[(4-cyclopropylmethoxy-2-pyridyl)methyl]thionyl]-1h-ben zimidazole | |
IL103798A (en) | Indole derivatives pharmaceutical compositions containing them and intermediates for their preparation | |
IL81349A0 (en) | Vinylphenol derivatives,their preparation and pharmaceutical compositions containing them | |
TNSN99191A1 (en) | NOVEL ADENINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
AU2458392A (en) | Novel medical use for tachykinin antagonists | |
IL101162A0 (en) | Pharmaceutical compositions for oral administration comprising an indole derivative | |
NO166448C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDE INDIANS. | |
NO894616D0 (en) | PROCEDURE FOR THE PREPARATION OF ANTI-Atherosclerotic Active Diaryl Compounds. | |
DK122391D0 (en) | THERAPEUTIC ACTIVITY, SUBSTITUTED BENZIMIDAZOLD DERIVATIVES AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, AND PROCEDURE FOR PREPARING SAME | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
BG60101B2 (en) | Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le | |
GEP19981392B (en) | N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof | |
DE69318715D1 (en) | PHARMACOLOGICALLY ACTIVE ALPHA- (TERTIARY-AMINOETHYL) -PHENYLMETHANOL DERIVATIVES | |
ATE219378T1 (en) | ESRAMUSTINE FORMULATIONS WITH IMPROVED PROPERTIES | |
JO1653B1 (en) | Benzimidazole process for its preparation |